|국가/구분||United States(US) Patent 등록|
|발명자 / 주소|
|출원인 / 주소|
|인용정보||피인용 횟수 : 19 인용 특허 : 0|
The effective ingredient in the inventive inhibitive agent against activity of a a
A method of providing a therapeutic effect for diabetes in a human in need thereof mediated by inhibiting the activity of a0.3g to 10 g per day of at least one gallated catechin compound or theaflavin compound selected from the group consisting of epigallocatechin gallate, isomer of epigallocatechin gallate, epicatechin gallate, isomer of epicatechin gallate, free theaflavin, theaflavin monogallate A, theaflavin monogallate B and theaflavin digallate.